Try our beta test site
284 studies found for:    "Whooping cough"
Show Display Options
Rank Status Study
21 Recruiting The PertADO Geneva Trial
Condition: Pertussis
Interventions: Biological: Pertagen® aP + Td-pur®;   Biological: Boostrix® dTpa
22 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
Condition: Pertussis
Interventions: Biological: diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis;   Biological: diphtheria-tetanus vaccine
23 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
Condition: Pertussis
Interventions: Biological: whole-cell pertussis vaccine;   Biological: diphtheria-tetanus vaccine
24 Completed
Has Results
Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
Condition: Pertussis
Intervention: Biological: Tetanus Toxoid, acellular pertussis, diphtheria toxoid
25 Completed Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants
Conditions: Diphtheria;   Acellular Pertussis;   Tetanus
Intervention: Other: Retrospective database study using administrative claims data
26 Active, not recruiting Influence of BCG on TDaP-IPV Vaccination
Condition: Whooping Cough
Interventions: Biological: BCG vaccine (SSI);   Biological: TDaP-IPV vaccine
27 Active, not recruiting Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates
Conditions: Hib Immunisation in Very Preterm-born Infants;   Pertussis Immunisation in Very Preterm-born Infants
Interventions: Biological: Three vaccine injections DTP-pertussis-Hib;   Biological: Two vaccine injections DTP-pertussis-Hib
28 Active, not recruiting TDAP Safety in Pregnant Women
Condition: Pertussis
Intervention:
29 Completed
Has Results
Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)
Condition: Pertussis
Interventions: Biological: aP booster;   Biological: TdaP booster;   Biological: Licensed TdaP booster (Boostrix®)
30 Recruiting Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
Conditions: Diphtheria;   Acellular Pertussis;   Tetanus
Intervention: Other: Pertussis maternal immunization
31 Active, not recruiting Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
Conditions: Tetanus;   Diphtheria;   Whooping Cough
Interventions: Biological: Biological: GC3111 vaccine;   Biological: Biological: Boostrix® vaccine
32 Completed Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4- to 5 Year Old Children Previously Vaccinated With VAXELIS or INFANRIX Hexa
Conditions: Hepatitis B;   Pertussis
Intervention: Other: Blood Sample
33 Completed Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.
Conditions: Acellular Pertussis;   Diphtheria;   Tetanus
Intervention: Biological: Prophylaxis: Diphtheria, tetanus and pertussis
34 Active, not recruiting Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Conditions: Tetanus;   Diphtheria;   Pertussis;   Whooping Cough
Interventions: Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1;   Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 2;   Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 3;   Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 4;   Biological: Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed;   Biological: Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
35 Active, not recruiting Pertussis Maternal Immunization Study
Condition: Pregnant Women
Interventions: Biological: Tdap;   Biological: Td
36 Recruiting Pertussis and Meningitis C Concomitant Vaccination in Adolescents
Conditions: Pertussis;   Meningitis;   Preventive Immunization; Meningitis;   Immunization
Interventions: Biological: Meningococcal vaccine;   Drug: Pertussis containing vaccine
37 Completed
Has Results
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents
Conditions: Pertussis;   Tetanus;   Diphtheria
Intervention: Biological: (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis
38 Unknown  An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Td5ap;   Biological: Td1aP
39 Completed
Has Results
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
Conditions: Pertussis;   Whooping Cough;   Tetanus;   Lockjaw;   Diphtheria
Interventions: Biological: Acellular pertussis vaccine;   Biological: Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed);   Biological: Licensed TdaP booster vaccine;   Biological: Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany);   Other: Saline solution
40 Completed Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine
Condition: Diphteria, Tetanus and Pertussis
Interventions: Biological: GSK Biologicals' reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine;   Biological: GSK Biologicals' reduced-antigen-content acellular pertussis vaccine;   Biological: Tedivax-Adult™/ Td-Rix™

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.